Generic pain injection put to the test against Brand-Name drug
NCT ID NCT06902090
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study tests a generic version of meloxicam nanocrystal injection (a pain reliever) against the brand-name drug ANJESO® in 20 healthy adults aged 18 to 45. Researchers compare how the body absorbs and processes each drug, and check for side effects. The goal is to see if the generic version is safe and behaves similarly to the original.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
meloxicam nanocrystal injection
What this could lead to
If successful, this could show that the generic version works similarly to the brand-name drug, potentially offering a more affordable pain treatment option.
What could go wrong
This is an early-phase study with only 20 healthy people, so it cannot prove the drug works for pain. Side effects are possible, and results may not apply to patients with pain conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China